News
Hyphens Pharma has completed the second tranche of acquiring 17% of shares in Ardence Pharm for a consideration of $3.35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results